Sign in
4

Changes in Ownership

Fulcrum Therapeutics, Inc. Filed Acc 0001104659-22-130982

10% owner bought 4,089 shares at $5.99 ($24,510)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
RA CAPITAL MANAGEMENT, L.P. 10% owner 2022-12-27 Purchase +4,089 $5.99 $24,510 9,505,925 I
Open-market purchases · 4,089 sh · avg $5.99 · $24,510
Loading xslF345X03/tm2233686-1_4seq1.xml…